Woodley Equipment Company Acquires Blinded Diagnostics
pharmafile | December 11, 2018 | News story | Research and Development | POCT, Point of Care Testing, clinical research, clinical trials, point-of-care testing
HORWICH, BOLTON Dec1 2018: Woodley Equipment Company Inc, a leading global supplier of rental equipment for use in Clinical Trials has announced its acquisition of Blinded Diagnostics, a pioneering contract service organization specializing in sourcing and support of decentralized test platforms.
Woodley Equipment Company provides a range of tailored management services from sourcing and supplying study equipment to international logistics and end of trial disposal; the acquisition of Blinded Diagnostics will build strategic customer value through knowledge of the protocol design and analysis, Investigator training and firmware encryption.
The combined business will realise an extended, specialist service proposition that’s unique within the Clinical Trials sector; accelerating the group’s marketing penetration with both CROs (Contract Research Organisations) and Study Sponsors (Pharmaceutical and Biotech companies).
Over the last decade, pharmaceutical companies have discovered the benefits of using hand held, portable and table top Point-of-Care devices in large Clinical Trials, as the challenge to deliver patient-centric Studies increases. Clinical Trials that are designed to evaluate pharmaceuticals require a variety of diagnostic tests to be performed on all enrolled patients; making POCT (Point of Care Testing) an integral part of the Study Protocol.
Woodley already works with the many of the World’s leading CRO’s supporting over 300 Clinical Trials in 150 countries. Now, Blinded’s complimentary focus on Point of Care Testing (POCT) will further enhance Woodley’s expertise in diagnostic equipment (which is also supported by an existing team of in-house Biomedical Scientists).
Robin Wickham, CEO for Woodley Clinical Trials commented, “The coming together of Woodley Equipment Company and Blinded Diagnostics is 100% complementary in terms of service provision, industry focus and international aspiration, and I am excited that working together we can accelerate our next phase of growth in the US, Europe and Asia Pacific through a truly differentiated customer offer”
Blinded Diagnostics will be recognised as a key Division of Woodley Equipment Company, integrating operationally in the areas of customer management, equipment sourcing and financial infrastructure. Steve Karuppan, CEO Blinded Diagnostics added: “We are truly thrilled to become part of the Woodley Group. We believe that this will enable Blinded to concentrate on providing knowledge and training expertise with absolute confidence that equipment recommendations and logistics are being managed by the very best team in the Clinical Trials sector”
About Woodley Equipment Services
With a heritage stretching back 30 years, Woodley Equipment Company is a world leading, one-stop supplier of equipment solutions for the Clinical Trials industry. As a private company, Woodley was established in October 1989 and now operates from three offices and warehouse premises in the North West of England and from office and warehouse premises in New York, USA.
Woodley Equipment Company is the supplier of choice for many of the largest companies in Clinical Research, as well as the partner of small and medium sized companies around the world. Developing a network of suppliers and service providers around the globe, Woodley has successfully grown, establishing a reputation for consistently providing quality, reliable equipment services. This is reflected in the achievement of an ISO 9001:2015 accreditation recognising the quality of Woodley’s administrative and managements systems.
A streamlined management system and an ever-growing network of trusted, specialist suppliers means that Woodley Equipment Company is well placed to provide the highest level of customer service and the best value equipment solutions.
Woodley provides a complete global service that includes sourcing, supplying and maintaining the equipment and consumable items needed Clinical Trials. This service eliminates the need for multiple providers; increasing equipment traceability and ensuring compliance with ISO, FDA, GCP and the Sunshine Act.
For further information about Woodley Equipment Company visit
https://www.woodleyequipment.com/clinical-trials
About Blinded Diagnostics
A pioneering contract service organization specializing in sourcing and supporting decentralized test platforms for pharmaceutical clinical trials. Blinded Diagnostics has a successful track record of expertise in meeting large pharmaceutical company testing needs with thorough knowledge of the protocol design, Investigator training and firmware encryption. As an innovator with partners in point-of-care diagnostics, Blinded Diagnostics is at the forefront of a paradigm shift that brings flexibility and efficiency for trial sponsors.
Related Content
Gilead and Merck share data from phase 2 trial of HIV treatment
Gilead Sciences and Merck (known as MSD outside of the US and Canada) have announced …
FDA clears Aruna Bio’s IND for AB126 to enter clinical trials
Aruna Bio has announced that the US Food and Drug Administration (FDA) has cleared its …
Genentech shares phase 3 results for ALK-positive early-stage lung cancer treatment
Roche’s Genentech has announced that the phase 3 ALINA trial assessing Alecensa, compared with platinum-based …
